Get the Stockscreener App
14.38
3.98%
0.55
Embecta Corp stock is traded at $14.38, with a volume of 883.80K.
It is up +3.98% in the last 24 hours and up +34.52% over the past month.
Embecta Corp is a medical device company focused on providing solutions to improve the health and well-being of people living with diabetes. It has a broad portfolio of marketed products, including various pen needles, syringes, and safety devices, which are complemented by a proprietary digital application designed to assist people with managing their diabetes. The company predominantly sells products to wholesalers and distributors that sell to retail and institutional channels who in turn sell to patients or use the products to deliver insulin injections to patients. It also provides contract manufacturing services. Geographically, the company derives a majority of its revenue from the United States.
See More
Previous Close:
$13.83
Open:
$14
24h Volume:
883.80K
Relative Volume:
1.29
Market Cap:
$841.02M
Revenue:
$1.12B
Net Income/Loss:
$55.30M
P/E Ratio:
15.14
EPS:
0.95
Net Cash Flow:
$-30.30M
1W Performance:
+5.04%
1M Performance:
+34.52%
6M Performance:
+1.99%
1Y Performance:
+9.02%
1-Day Range:
$13.90
$14.84
1-Week Range:
$13.35
$14.84
52-Week Range:
$9.20
$21.48
Embecta Corp Stock (EMBC) Company Profile
Name
Embecta Corp
Sector
Industry
Phone
(862) 401-0000
Address
1209 ORANGE STREET, WILMINGTON
Compare EMBC with other stocks
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
EMBC
Embecta Corp
|
14.38 | 788.38M | 1.12B | 55.30M | -30.30M | 0.95 |
|
ISRG
Intuitive Surgical Inc
|
476.16 | 172.53B | 9.15B | 2.63B | 1.99B | 7.17 |
|
BDX
Becton Dickinson Co
|
199.66 | 55.89B | 21.39B | 1.61B | 2.55B | 5.56 |
|
ALC
Alcon Inc
|
82.02 | 43.59B | 9.93B | 1.12B | 1.43B | 2.26 |
|
RMD
Resmed Inc
|
293.73 | 41.89B | 5.15B | 1.40B | 1.65B | 9.51 |
|
WST
West Pharmaceutical Services Inc
|
247.85 | 17.48B | 2.96B | 487.70M | 344.00M | 6.68 |
Embecta Corp Stock (EMBC) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Apr-10-25 | Initiated | Mizuho | Neutral |
| Dec-02-24 | Upgrade | Morgan Stanley | Underweight → Equal-Weight |
| Nov-27-24 | Upgrade | BTIG Research | Neutral → Buy |
| Oct-20-23 | Initiated | Wolfe Research | Peer Perform |
| Jan-06-23 | Downgrade | Morgan Stanley | Equal-Weight → Underweight |
| Sep-08-22 | Initiated | BTIG Research | Neutral |
| Aug-01-22 | Initiated | Morgan Stanley | Equal-Weight |
| Jun-21-22 | Initiated | BofA Securities | Underperform |
View All
Embecta Corp Stock (EMBC) Latest News
Traders Consider Averaging Down in Embecta Corp.2025 Retail Activity & Weekly Watchlist of Top Performers - classian.co.kr
Pen Needles Company Evaluation Report 2025 | Embecta, Novo Nordisk, and B. Braun Dominate with Strong Portfolios, Innovation, and Expansive Distribution - Yahoo Finance
RSI Crosses Above 30 for Embecta Corp. — Reversal in Sight2025 Technical Overview & Low Risk Investment Opportunities - beatles.ru
Is now a turning point for Embecta Corp.Quarterly Performance Summary & Community Trade Idea Sharing Platform - Newser
Why Embecta Corp. stock attracts strong analyst attention2025 Earnings Surprises & Daily Stock Trend Reports - Newser
Historical volatility pattern of Embecta Corp. visualizedInsider Buying & Weekly Watchlist for Consistent Profits - Newser
Embecta Corp. stock outlook for YEARPortfolio Growth Summary & Accurate Entry and Exit Point Alerts - Newser
What MACD signals say about Embecta Corp.Portfolio Risk Summary & Fast Gaining Stock Strategy Reports - Newser
Will Embecta Corp. see short term momentumJuly 2025 Closing Moves & High Return Stock Watch Alerts - Newser
Visual trend scoring systems applied to Embecta Corp.Trade Performance Summary & Weekly Watchlist of Top Performers - Newser
Pattern Scan Adds Embecta Corp. to WatchlistJuly 2025 Reactions & Safe Entry Momentum Stock Tips - thegnnews.com
Are Embecta's (EMBC) Earnings Growth Sustainable Amid Operational Headwinds and Geopolitical Risks? - AInvest
Embecta's (NASDAQ:EMBC) Profits May Not Reveal Underlying Issues - Yahoo Finance
Will Embecta Corp. benefit from macro trendsWeekly Trading Summary & Verified Momentum Stock Watchlist - Newser
Embecta Corp. stock trend forecastExit Point & Daily Technical Forecast Reports - Newser
PNC Financial Services Group Inc. Has $343,000 Stake in Embecta Corp. (NASDAQ:EMBC) - Defense World
Embecta (NASDAQ:EMBC) Stock Rating Upgraded by Wall Street Zen - Defense World
What’s the recovery path for long term holders of Embecta Corp.July 2025 Market Mood & Fast Exit and Entry Strategy Plans - Newser
Is Embecta Corp. building a consolidation baseMarket Rally & Real-Time Volume Analysis Alerts - Newser
Embecta Corp. Reports Record Revenue and Debt Reduction - MSN
Can swing trading help recover from Embecta Corp. lossesPortfolio Return Summary & Low Risk Growth Stock Ideas - Newser
Embecta Corp. (NASDAQ:EMBC) Q3 2025 Earnings Call Transcript - MSN
Day 5 of Gains Streak for Embecta Stock with 41% Return (vs. -31% YTD) [8/13/2025] - Trefis
Wall Street Analysts Predict a 25.69% Upside in Embecta Corp. (EMBC): Here's What You Should Know - NewsBreak: Local News & Alerts
Natixis Advisors LLC Sells 7,984 Shares of Embecta Corp. (NASDAQ:EMBC) - Defense World
Embecta To Go Ex-Dividend On August 29th, 2025 With 0.15 USD Dividend Per Share - 富途牛牛
Intraday Charts Show Spike in Embecta Corp. ActivitySecure Return Focused Investment Plan Released - beatles.ru
Market Cool On Embecta Corp.'s (NASDAQ:EMBC) Earnings - 富途牛牛
Embecta Corp. shares rise 1.06% intraday due to positive outlook in the insulin delivery device market. - AInvest
Embecta Corp (EMBC) Stock: A Year of Stock Market Dynamics - investchronicle.com
Mizuho raises Embecta stock price target to $14 on strong Q3 results - Investing.com Nigeria
Mizuho raises Embecta stock price target to $14 on strong Q3 results By Investing.com - Investing.com South Africa
Bloomberg Finance Expert Creates Essential Title for News Passage - AInvest
What makes Embecta Corp. stock price move sharplySmart Exit Timing Suggestions - mustnews.co.kr
Can Embecta Corp. deliver consistent EPS growthFree Entry and Exit Planner - sisaissue.com
Embecta Corp's Q3 2025 Outperformance: A Strategic Re-rating Opportunity Amid Margin Stability and Debt Reduction - AInvest
Embecta's 2025 Revenue Outlook: Navigating Regional Challenges and Valuation Opportunities - AInvest
This Embecta Insider Increased Their Holding By 20% Last Year - simplywall.st
Wyckoff Accumulation Phase Possible in Embecta Corp.Swing Trade Entry With Volume Triggers Released - beatles.ru
Embecta 2025 Q3 Earnings Strong Performance as Net Income Surges 209.5% - AInvest
Embecta outlines revenue range of $1.078B-$1.085B for 2025 amid U.S. strength and China headwinds - MSN
Embecta (NASDAQ:EMBC) Shares Gap Up Following Better-Than-Expected Earnings - Defense World
Embecta Corporation Reports Strong Q3 2025 Results - TipRanks
What are the risks of holding Embecta Corp.Weekly Alpha Generating Watchlist - thegnnews.com
Healthcare Stocks Move in Friday's Pre-Market Session: OptimizeRx, Embecta, and More - AInvest
Embecta Beat Estimates And Raised Its Outlook For The Year - Finimize
Embecta (EMBC.O) Surges 16.55% — But No News. What’s Driving This Move? - AInvest
Embecta Shares Rise on 2Q Profit, Revenue Beat - 富途牛牛
Embecta stock gets a boost on Q3 beats, raised guidance - Drug Delivery Business
Embecta Q3 2025 Earnings Call Transcript - MarketBeat
Embecta Corp.'s Q3 2025 Earnings Call: Navigating Key Contradictions in Tariffs, Demand, and Financial Strategy - AInvest
Embecta Corp Stock (EMBC) Financials Data
Revenue
Net Income
Cash Flow
EPS
Embecta Corp Stock (EMBC) Insider Trading
| Insider Trading | Relationship | Date | Transaction | Cost | #Shares | Value ($) | #Shares Total |
|---|---|---|---|---|---|---|---|
| Melcher David F | Director |
Feb 25 '25 |
Buy |
13.67 |
13,000 |
177,646 |
76,681 |
| Morris Milton Mayo | Director |
Feb 13 '25 |
Sale |
16.38 |
3,100 |
50,783 |
36,133 |
6.33%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):